BXP vs PLD
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
BXP exhibits a stable but fragile financial health with a Piotroski F-Score of 4/9, while valuation metrics suggest the stock is significantly overpriced. The current price of $57.73 trades at a steep premium to the Graham Number ($35.65) and the Intrinsic Value ($12.18). Severe revenue contraction (-31.90% YoY) and an unsustainable dividend payout ratio of 193.10% indicate a high risk of capital erosion or dividend cuts. Despite bullish analyst targets, the deterministic data and bearish insider activity point toward a value trap.
PLD exhibits a stable but mediocre Piotroski F-Score of 4/9, indicating a lack of strong fundamental momentum. The stock is trading at a severe premium, with a current price of $139.77 far exceeding both the Graham Number ($67.96) and the Intrinsic Value ($59.06). While the company maintains dominant market margins and a healthy debt-to-equity ratio, the unsustainable dividend payout ratio of 113.48% and an astronomical PEG ratio of 108.01 signal extreme overvaluation. Technical trends and insider selling further reinforce a bearish outlook despite analyst 'buy' ratings.
Compare Another Pair
Related Comparisons
BXP vs PLD: Head-to-Head Comparison
This page compares BXP, Inc. (BXP) and Prologis, Inc. (PLD) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.